These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 14196814)
1. [USE OF HOMOTYPIC ORAL ANTIPOLIOMYELITS VACCINATION IN AN EPIDEMIC CAUSED BY TYPE I POLIOMYELITIS VIRUS IN FRANCE]. DEBRE R; COULON G; LEDOURNEUF G; GAUTIER M; CELERS J; DROUHET V; BOUE A Bull World Health Organ; 1964; 30(5):663-74. PubMed ID: 14196814 [No Abstract] [Full Text] [Related]
2. [Type I poliomyelitis epidemic in France and use of homotypic vaccine (Sabin I LSc 2 ab) by oral administration. II. Study of the results of vaccination. Characterization of the virus eliminated by the vaccines]. Boué A; Drouhet V Arch Gesamte Virusforsch; 1966; 18(1):59-71. PubMed ID: 4294187 [No Abstract] [Full Text] [Related]
3. [Type I poliomyelitis epidemic in France and use of homotypic vaccine (Sabin LSc 2ab). 3. Study of the non-poliomyelitic enteric virus isolated before and after vaccination. Predominance of Coxsackie A7 virus]. Netter R; Drouhet V; Grist NR; Delpy J Arch Gesamte Virusforsch; 1966; 18(1):72-9. PubMed ID: 4294188 [No Abstract] [Full Text] [Related]
4. [Type I poliomyelitis epidemic in France and use of homotypic vaccine (Sabin LSc 2ab) by oral administration. 1. Virological and serological study of clinical cases and viral spread in schools and the environment of patients before oral vaccination]. Drouhet V; Netter R; Celers J Arch Gesamte Virusforsch; 1966; 18(1):49-58. PubMed ID: 4294186 [No Abstract] [Full Text] [Related]
5. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708 [TBL] [Abstract][Full Text] [Related]
6. [Research during a poliomyelitis epidemic having given rise to a vaccination campaign with live homotypic vaccine]. Debré R; Celers J; Drouhet V; Boué A; Netter R Bull Acad Natl Med; 1965 Jun; 149(22):562-70. PubMed ID: 5321217 [No Abstract] [Full Text] [Related]
7. [USE OF HOMOTYPE ORAL ANTIPOLIOMYELITIC VACCINE DURING AN EPIDEMIC OCCURRING IN FRANCE AND DUE TO TYPE I POLIOMYELITIS VIRUS]. DEBRE R; COULON G; LEDOURNEUF G; GAUTIER M; CELERS J; DROUHET V; BOUE A Bull Acad Natl Med; 1964 Feb 4-11; 148():75-86. PubMed ID: 14136499 [No Abstract] [Full Text] [Related]
8. [Attempt to interpret some cases and research during a type I poliomyelitis epidemic having given rise to a vaccination campaign by homotypic live vaccine]. Debré R; Celers J; Drouhet V; Boué A; Netter R Bull World Health Organ; 1965; 33(5):593-606. PubMed ID: 5295140 [No Abstract] [Full Text] [Related]
10. [EXPERIMENTS ON VIRAL EXCRETION AND SERUM DIFFERENTIATION DURING A POLIOMYELITIS EPIDEMIC FOLLOWING ORAL VACCINATION WITH POLIOVIRUS TYPE-3]. DEIBEL R; HORSTMANN W Klin Wochenschr; 1965 May; 43():570-3. PubMed ID: 14304400 [No Abstract] [Full Text] [Related]
11. [PROBLEMS OF POLIOMYELITIS VACCINATION]. PAVILANIS V Union Med Can; 1964 Nov; 93():1303-6. PubMed ID: 14227008 [No Abstract] [Full Text] [Related]
12. [REACTIONS AND COMPLICATIONS FOLLOWING ORAL POLIOMYELITIS VACCINATION. I]. JOPPICH G; KOLLER S Dtsch Med Wochenschr; 1965 Jul; 90():1197-200. PubMed ID: 14303427 [No Abstract] [Full Text] [Related]
13. [REACTIONS AND COMPLICATIONS FOLLOWING ORAL POLIOMYELITIS VACCINATION. II]. PETTE H Dtsch Med Wochenschr; 1965 Jul; 90():1200-3. PubMed ID: 14303428 [No Abstract] [Full Text] [Related]
14. Paralytic poliomyelitis caused by a vaccine-derived polio virus in an antibody-deficient Argentinean child. Hidalgo S; García Erro M; Cisterna D; Freire MC Pediatr Infect Dis J; 2003 Jun; 22(6):570-2. PubMed ID: 12828159 [TBL] [Abstract][Full Text] [Related]
15. [ON A CASE OF ACUTE HEMORRHAGIC GLOMERULONEPHRITIS IN THE COURSE OF SABIN TYPE POLIO VACCINATION]. GAMALERO PC; CANESTRI G G Mal Infett Parassit; 1965 May; 17():293-4. PubMed ID: 14341362 [No Abstract] [Full Text] [Related]
16. [CONTRIBUTION TO THE PROBLEM OF COMPLICATIONS FOLLOWING ORAL POLIOMYELITIS VACCINATION]. GERSTENBRAND F; PROSENZ P; REISNER H Wien Klin Wochenschr; 1965 Jan; 77():1-7. PubMed ID: 14273291 [No Abstract] [Full Text] [Related]
17. COMMENTARY ON REPORT ON ORAL POLIOMYELITIS VACCINES. SABIN AB JAMA; 1964 Oct; 190():52-5. PubMed ID: 14197145 [No Abstract] [Full Text] [Related]
18. [APROPOS OF VACCINAL COMPLICATIONS AFTER ORAL POLIOMYELITIS VACCINATION THE PREVIOUS YEAR]. SOLLBERG G Nervenarzt; 1964 Jul; 35():308-9. PubMed ID: 14257125 [No Abstract] [Full Text] [Related]
20. [A poliomyelitis epidemic caused by poliovirus type 3 in the region of Poznan in 1968. Preliminary communication]. Walter T Zentralbl Bakteriol Orig; 1968; 209(1):134-7. PubMed ID: 4318103 [No Abstract] [Full Text] [Related] [Next] [New Search]